Kola Otitoju Named Chief Business & Strategy Officer at 908 Devices

908 Devices Inc. has appointed Kola Otitoju as its chief business and strategy officer, a newly created position. He will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as the company expands its market presence across public health, safety, and defense-tech applications.

Otitoju has more than 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he was senior vice president of Strategy & Business Development at Repligen Corporation, where he led global corporate strategy and executed more than 15 M&A transactions and strategic partnerships over six years, supporting the company’s approximately 20% compound annual growth rate and driving revenue to over $700 million.

“We are thrilled to welcome Kola to 908 Devices as we build on the momentum of our 2.0 transformation and enter our next phase of growth,” 908 Devices Co-Founder/CEO Kevin J. Knopp stated. “His track record in driving both organic and inorganic growth makes him the ideal leader to accelerate our strategic initiatives and deliver long-term shareholder value. M&A and industry partnerships have already been successful and integral to our strategy, and we intend to lean in further. Kola’s appointment reinforces this commitment and positions us to execute at an even higher level.”

Prior to Repligen, Otitoju held senior strategy and business development roles at Candela Medical (an Apax Partners portfolio company), Baxter International, and GE Healthcare, where he served as managing director and head of Business Development. Earlier in his career, he spent eight years in investment banking at Credit Suisse and Bank of America Securities, advising on M&A transactions across healthcare, industrials, and technology sectors.

Otitoju earned an MBA from Harvard Business School, a master’s degree in electrical engineering from Cornell University, and a bachelor’s degree in information systems from Imperial College, London.

908 Devices is attempting to revolutionize chemical analysis with its simple handheld devices, addressing life-altering applications. The company’s devices are used at the point of need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety, and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The company designs and manufactures products that bring together the power of complementary analytical technologies, software automation, and machine learning.